Thirona Retina visited 100% Optical conference in London, presenting amazing results of a recent study with InHealth Intelligence. 

The annual London 100% Optical conference has again proved to be a platform for the future developments in the eye care optical market with Thirona Retina’s AI-based solution RetCAD at the forefront of technical innovation. 

Breakthrough results of the recent study comparing the human graders with the RetCAD newest software release were presented at the conference. The study was conducted retrospectively on 10 000 patients who were screened as part of the routine NHS diabetic eye screening program. The software results proved to be very comparable to human specialists, showing a sensitivity of 95.4% and specificity of 92.0% for detecting referable diabetic retinopathy; i.e. stages of DR that would require a pathway changing action during routine screening.  

This study proves that RetCAD can significantly reduce the workload of manual grading and provide trustworthy results even when used in large scale population screening programs. 

Having not one case missed, RetCAD became a very strong case for AI implementation into DR screening programs, as well as for routine check ups conducted by opticians and optometrists.

You can read the full study in the Diabetic Medicine Journal.